The study of complex traits in humans and model organisms has made considerable progress in recent years. Multi-dimensional high-resolution genomics data and immunological data allows to study complex biological networks, and the dynamics of cellular state and function at a resolution not possible before. The usage of these technologies require, however, highly specialized expertise in genomics, immunology, and computational biology. The primary goal of the Multiparametric Host Cell Analysis (MHC) Core is to provide members of the University of Chicago (UChicago) Digestive Diseases Research Core Center (DDRCC) for Interdisciplinary Study of Inflammatory Intestinal Disorders (C-IID) with such level of expertise, further promoting the usage of state-of-the-art genomic technologies in gastrointestinal research. Specifically, the MHC core will provide the community: (i) consulting service for human tissue isolation, analysis and cell sorting protocols adapted to the different forms of assays, (ii) consulting services and development of customized antibody panels for high resolution cellular tissue profiling of human samples using spectral flow cytometry, (iii) advanced flow cytometry sorting of 6 different populations of cells from a tissue sample based on the detection of 28 fluorescence marker using an advanced BD Biosciences sorter (FACSymphony S6 High Parameter Cell Sorter), (iv) advise with the study design of genomic experiments; (v) a series of pre-optimized genomic assays (e.g., single-cell RNA-seq, epigenetic profiles); (vi) standardized and validated analytical pipelines for the analyses of different genomic datasets, and (vii) bioinformatics support for genomic and flow cytometry data analysis. The standardization of experimental protocols and analytical pipelines offered by the core will help minimize the errors during data collection, management, maintenance, and, importantly, facilitate downstream data integration and sharing among C-IID members.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
2P30DK042086-31
Application #
10049112
Study Section
Special Emphasis Panel (ZDK1)
Project Start
1996-12-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
31
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Amin, Ruhul; Asplin, John; Jung, Daniel et al. (2018) Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria. Kidney Int 93:1098-1107
Miyoshi, Jun; Nobutani, Kentaro; Musch, Mark W et al. (2018) Time-, Sex-, and Dose-Dependent Alterations of the Gut Microbiota by Consumption of Dietary Daikenchuto (TU-100). Evid Based Complement Alternat Med 2018:7415975
Lu, Jing; Lu, Lei; Yu, Yueyue et al. (2018) Effects of Intestinal Microbiota on Brain Development in Humanized Gnotobiotic Mice. Sci Rep 8:5443
Meisel, Marlies; Hinterleitner, Reinhard; Pacis, Alain et al. (2018) Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557:580-584
Chen, Edmund B; Cason, Cori; Gilbert, Jack A et al. (2018) Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions. J Gastrointest Surg 22:1112-1123
Chew, Justin; Leypunskiy, Eugene; Lin, Jenny et al. (2018) High protein copy number is required to suppress stochasticity in the cyanobacterial circadian clock. Nat Commun 9:3004
Ruderman, Sarah; Eshein, Adam; Valuckaite, Vesta et al. (2018) Early increase in blood supply (EIBS) is associated with tumor risk in the Azoxymethane model of colon cancer. BMC Cancer 18:814
McIntosh, Christine M; Chen, Luqiu; Shaiber, Alon et al. (2018) Gut microbes contribute to variation in solid organ transplant outcomes in mice. Microbiome 6:96
Dugas, Lara R; Lie, Louise; Plange-Rhule, Jacob et al. (2018) Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol. BMC Public Health 18:978
Panés, Julian; Vermeire, Séverine; Lindsay, James O et al. (2018) Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies. J Crohns Colitis 12:145-156

Showing the most recent 10 out of 697 publications